T-Cell-Activation Inhibitors in Rheumatoid Arthritis

ISSN： 1173-8804

Source： BioDrugs, Vol.17, Iss.4, 2003-01, pp. : 263-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis

By Chung Y.-L. Lee M.-Y. Wang A.-J. Yao L.-F.

Molecular Therapy, Vol. 8, Iss. 5, 2003-11 ,pp. : 707-717

Elsevier

Access to resources Recommend Favorite

Rituximab: In Rheumatoid Arthritis

By Frampton James E. Scott Lesley J.

BioDrugs, Vol. 21, Iss. 5, 2007-01 ,pp. : 333-341

Adis International

Access to resources Recommend Favorite

Abatacept for rheumatoid arthritis

By Rojahn Ruth

International Journal of Evidence-based Healthcare, Vol. 9, Iss. 4, 2011-12 ,pp. : 456-457

Blackwell Publishing

Access to resources Recommend Favorite

Certolizumab Pegol: In Rheumatoid Arthritis

By Duggan Sean T. Keam Susan J.

BioDrugs, Vol. 23, Iss. 6, 2009-12 ,pp. : 407-417

Adis International

Access to resources Recommend Favorite

Vocational rehabilitation for persons with rheumatoid arthritis

By Allaire S.H.

Journal of Vocational Rehabilitation, Vol. 10, Iss. 3, 1998-06 ,pp. : 253-260

Elsevier

Access to resources Recommend Favorite